NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy
Clinical trial NCT04781309 · COMPLETED
Trial details
- NCT number
- NCT04781309
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2025-11-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.